Key stats
About NYLI U.S. Large Cap R&D Leaders ETF
Home page
Inception date
Feb 8, 2022
Structure
Open-Ended Fund
Distributes
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Tax on distributions
Qualified dividends
Primary advisor
New York Life Investment Management LLC
Distributor
Alps Distributors, Inc.
LRND focuses on large-cap US companies with the highest expenditures on research and development (R&D). This is expected for innovation and development of concepts for new products or services by which the company can increase revenues. The issuer believes R&D spending is an indicator of a firms growth potential and expansion capabilities. Starting with the Russell 1000 Index constituents, the fund selects and weights the top 100 companies based on the most recently reported dollar amount of R&D spending during the previous year. The fund pulls the R&D data from a FactSet standardized table which aims to reconcile companies reporting differences. The index reconstitutes and rebalances quarterly so that no individual security exceeds 5% weight. LRND is part of IndexIQs Research and Development ETFs suite along with MRND and WRND, which focuses on US mid-caps and global equities, respectively. Prior to Aug. 28, 2024, the fund name was branded under IndexIQ.
Classification
What's in the fund
Exposure type
Technology Services
Electronic Technology
Health Technology
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.